Coagulase-negative staphylococcal sternal wound infections after open heart operations

Annals of Thoracic Surgery

Volumn 63, Issue 2, 1997, Pages 395-401

  Mossad, Sherif B ^a   Serkey, Janet M ^a   Longworth, David L ^a   Cosgrove III, Delos M ^a   Gordon, Steven M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; OXACILLIN; RIFAMPICIN; VANCOMYCIN;

ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; OPEN HEART SURGERY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; CARDIAC SURGICAL PROCEDURES; CASE-CONTROL STUDIES; COAGULASE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STERNUM; SURGICAL WOUND INFECTION; VANCOMYCIN;

EID: 0031059458     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)00834-X     Document Type: Article

References (32)

1. Loop FD, Lytle BW, Cosgrove DM, et al. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg 1990;49:179-87.
2. Sarr MG, Gott VL, Townsend TR. Mediastinal infection after cardiac surgery. Ann Thorac Surg 1984;38:415-23.
3. Newman LS, Szczukowski LC, Bain RP, Perlino CA. Suppurative mediastinitis after open heart surgery: a case control study of risk factors. Chest 1988;94:546-53.
4. Nagachinta T, Stephens M, Reitz B, Polk F. Risk factors for surgical-wound infection following cardiac surgery. J Infect Dis 1987;156:967-73.
5. Culliford AT, Cunningham JN Jr, Zeff RH, Isom OW, Teiko P, Spencer FC. Sternal and costochondral infections following open heart surgery: a review of 2,594 cases. J Thorac Cardiovasc Surg 1976;72:714-26.
6. Taylor GJ, Mikell FL, Moses HW, et al. Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications. Am J Cardiol 1990;65:309-13.
7. Boyce JM, Potter-Bynoe G, Dziobek L. Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol 1990;11:89-93.
8. Copeland M, Senkowski C, Ulcickas M, Mendelson M, Griepp RB. Breast size as a risk factor for sternal wound complications following cardiac surgery. Arch Surg 1994;129: 757-9.
9. He GW, Ryan WH, Acuff TE, et al. Risk factors for operative mortality and sternal wound infection in bilateral internal mammary artery grafting. J Thorac Cardiovasc Surg 1994; 107:196-202.
10. Hazelrigg SR, Wellons Jr. HA, Schneider JA, Kolm P. Wound complications after median sternotomy: relationship to internal mammary grafting. J Thorac Cardiac Surg 1989;98: 1096-9.
11. Grossi EA, Culliford AT, Krieger KH, et al. A survey of 77 major infectious complications of median sternotomy: a review of 7,949 consecutive operative procedures. Ann Thorac Surg 1985;40:214-23.
12. Kreter B, Woods M. Antibiotic prophylaxis for cardiothoracic operations: metaanalysis of thirty years of clinical trials. J Thorac Cardiovasc Surg 1992;104:590-9.
13. Archer GL, Tenenbaum MJ. Antibiotic-resistant Staphylococcus epidermidis in patients undergoing cardiac surgery. Antimicrob Agents Chemother 1980;17:269-72.
14. Woods M, Tillman D. Antibiotic prophylaxis in cardiothoracic surgery 1990: results of a third survey. Hosp Pharm 1992;27:404-7.
15. Archer GL, Armstrong BC. Alteration of staphylococcal flora in cardiac surgery patients receiving antibiotic prophylaxis. J Infect Dis 1983;147:642-9.
16. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-8.
17. Dean A. Epi-Info Software, Version 5.01, Centers for Disease Control and Prevention, Atlanta, Georgia.
18. Sellik Jr. JA, Stelmach M, Mylotte JM. Surveillance of surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol 1990;12:591-6.
19. L'Ecuyer PB, Murphy D, Little JR, Fraser VJ. The epidemiology of chest and leg wound infections following cardiothoracic surgery. Clin Infect Dis 1996;22:424-9.
20. Wilson APR, Gruneberg RN, Treasure T, Sturridge MF. Staphylococcus epidermidis as a cause of postoperative wound infection after cardiac surgery: assessment of pathogenicity by a wound-scoring method. Br J Surg 1988;75:168-70.
21. Gruer LD, Bartlett R, Ayliffe GAJ. Species identification and antibiotic sensitivity of coagualse-negative staphylococci from CAPD peritonitis. J Antimicrob Chemother 1984;13: 577-83.
22. Marsik FJ, Brake S. Species identification and susceptibility to 17 antibiotics of coagulase-negative staphylococci isolated from clinical specimens. J Clin Microbiol 1982;15:640-517.
23. John JF, Grieshop TJ, Atkins LM, Platt CG. Widespread colonization of personnel at a veterans affairs medical center by methicillin-resistant, coagulase-negative staphylococcus. Clin Infect Dis 1993;17:380-8.
24. Van Den Broek PJ, Lampe AS, Berbee GAM, Thompson J, Mouton RP. Epidemic of prosthetic valve endocarditis caused by Staphylococcus epidermidis. Br Med J 1985;291: 949-50.
25. Boyce JM, Potter-Bynoe G, Opal SM, Dziobek L, Medeiros AA. A common-source outbreak of Staphylococcus epidermidis infections among patients undergoing cardiac surgery. J Infect Dis 1990;161:493-9.
26. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992;326:281-6.
27. Kaiser AB, Petracek MR, Lea IV JW, et al. Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery: results of a prospective, randomized, double-blind trial in 1030 patients. Ann Surg 1987;206: 791-7.
28. Gentry LO, Zeluff BJ, Cooley DA. Antibiotic prophylaxis in open-heart surgery: a comparison of cefamandole, cefuroxime, and cefazolin. Ann Thorac Surg 1988;46:167-71.
29. Slama TG, Sklar SJ, Misinski J, Fess SW. Randomized comparison of cefamandole, cefazolin, and cefuroxime prophylaxis in open-heart surgery. Antimicrob Agents Chemother 1986;29:744-7.
30. Kernodle DS, Kaiser AB. Comparative prophylactic efficacy of cefazolin and vancomycin in a guinea pig model of Staphylococcus aureus wound infection. J Infect Dis 1993;168: 152-7.
31. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16: 105-13.
32. Sands K, Vineyard G, Platt R. Surgical site infections occur-ing after hospital discharge. J Infect Dis 1996;173:963-70.